Sunesis Pharmaceuticals Inc (SNSS)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -11.57M | -12.21M | -12.45M | -12.48M | -13.56M | -13.88M | -9.59M | -10.19M |
税引前収入 | -10.33M | -12.21M | -12.48M | -12.6M | -13.77M | -9.14M | -9.83M | -10.55M |
純利益 | -10.33M | -12.21M | -12.48M | -12.6M | -13.77M | -9.14M | -9.83M | -10.55M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -10.78M | -12.21M | -12.45M | -12.47M | -13.57M | -8.88M | -9.59M | -10.19M |
EBITDA | -11.52M | -12.09M | -12.33M | -12.35M | -13.44M | -13.77M | -9.49M | -10.08M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 2.54M | 669k | 237k | 2.07M | 120k | 13.5M | 0 | 0 |
営業利益 | -36.46M | -34.42M | -25.71M | -23.29M | -22.3M | -114.28M | -50.59M | -50.69M |
税引前収入 | -38.02M | -35.46M | -26.62M | -23.33M | -21.61M | -114.76M | -49.2M | -51.06M |
純利益 | -38.02M | -35.46M | -26.62M | -23.33M | -21.61M | -114.76M | -49.2M | -51.06M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.817 | -1.034 | -0.71 | -0.209 | -1.193 | -3.066 | -1.283 | -1.322 |
EBIT | -36.3M | -34.06M | -25.46M | -22.82M | -21.31M | -114.31M | -49.79M | -50.7M |
EBITDA | -36.45M | -34.41M | -25.7M | -23.29M | -22.3M | -114.1M | -50.38M | -50.2M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約